Study of two doses of ritlecitinib for alopecia areata
Treatments studied
Part of Skin clinical trials.
This study tests two different doses of a pill called ritlecitinib to see if it can help regrow hair in people with significant hair loss from alopecia areata. It is for people aged 12 and older who have lost at least half of their scalp hair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years or older (teens may need extra approvals).
- You have a confirmed diagnosis of alopecia areata with no other cause of hair loss.
- You have at least 50% scalp hair loss and no significant regrowth in the last 6 months.
- Your current hair loss episode started within the last 10 years.
- You have not had certain infections, hearing issues, or cancer (with some exceptions).
- You are not currently taking certain medications or participating in other trials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This study tests an investigational oral medication (deuruxolitinib) for adolescents with severe alopecia areata (hair loss). It aims to see if it can help hair regrow safely.
This study tests if the medicine ritlecitinib can help regrow hair in people with alopecia areata, a condition that causes patchy hair loss. It's for young people and adults who have lost between 20% and 50% of their scalp hair for at least 6 months but no more than 10 years.
This trial provides early access to an investigational drug called ritlecitinib for people with severe alopecia areata who have not responded to other treatments. It aims to help regrow hair by targeting the immune system.
This Phase 2 study tests ruxolitinib to see if it safely helps regrow hair in people whose alopecia areata is linked to APECED (a rare immune condition). You may qualify if you have significant scalp hair loss for at least 6 months and haven’t had regrowth with other treatments.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.